Treatment.com International Inc. (CSE: TRUE), a disruptive healthcare technology company that is harnessing the power of AI to help Canadians improve their health is pleased to announce a non-brokered private placement of up to 1,000,000 common shares (“share”) at a price of $5.00 per share for gross proceeds of up to $5,000,000 (the “Offering”).
In connection with the Offering, the Company may pay a finder’s fee within the amount permitted by the policies of the Canadian Securities Exchange (the “Exchange”).
Closing of the Offering is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the Exchange. All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation. The Offering is not subject to a minimum aggregate amount of subscriptions. The net proceeds from the Offering will be used for general corporate purposes and to execute the Company’s annual marketing plan.